Changes in the oxidant-antioxidant system activity in patients with hepatic failure treated with hyperbaric oxygenation and actoprotectors | Canada Hyperbarics Skip to main content
Study Anesteziol Reanimatol 1999

Changes in the oxidant-antioxidant system activity in patients with hepatic failure treated with hyperbaric oxygenation and actoprotectors

Lakhin R, Belozerova L, Maksimets V, Romanov D — Anesteziol Reanimatol, 1999

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated how hyperbaric oxygenation, bemitil, and solcoseryl affected the body's oxidant-antioxidant balance in patients with liver failure before surgery.

What They Found

The study found that hyperbaric oxygenation increased lipid peroxidation, a process that can damage cells. In contrast, bemitil reduced lipid peroxidation by boosting the antioxidant system. Solcoseryl's antioxidant effects were only stable after a full course of treatment and did not work through the same antioxidant pathway.

Canadian Relevance

No direct Canadian connection identified. This study does not cover a Health Canada-recognised indication for HBOT.

Study Limitations

This study was published in 1999 and is a single study, meaning its findings may not be broadly applicable without further modern research.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 10360076
Year Published 1999
Journal Anesteziol Reanimatol
MeSH Terms Actihaemyl; Antioxidants; Benzimidazoles; Humans; Hyperbaric Oxygenation; Lipid Peroxidation; Liver Failure; Malondialdehyde; Preoperative Care; Sulfhydryl Compounds

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology